Validating an empiric sulfadiazine–trimethoprim dosage regimen for treatment of Escherichia coli and Staphylococcus delphini infections in mink ( Neovison vison )
(2020)
Journal Article
Ronaghinia, A. A., Nikolaisen, N. K., Hansen, S. G., Poulsen, H. H., Frandsen, H. L., Struve, T., Toutain, P. L., & Damborg, P. (2020). Validating an empiric sulfadiazine–trimethoprim dosage regimen for treatment of Escherichia coli and Staphylococcus delphini infections in mink ( Neovison vison ). Journal of Veterinary Pharmacology and Therapeutics,
Antimicrobial agents are used extensively off‐label in mink, as almost no agents are registered for this animal species. Pharmacokinetic (PK) and pharmacodynamic (PD) data are required to determine antimicrobial dosages specifically targeting mink ba... Read More about Validating an empiric sulfadiazine–trimethoprim dosage regimen for treatment of Escherichia coli and Staphylococcus delphini infections in mink ( Neovison vison ).